ATOREX Mucosal Atomization Devices

ATOREX – Intranasal mucosal atomization device

ATOREX provides safe, easy, and fast delivery of medications to nasal mucosa. A fine mist of atomized particles are rapidly absorbed across mucosal membranes into the blood stream.

It reduces the need for intravenous access that can often be painful and upsetting for the patient.

Delivery of atomised medication is also relatively painless and requires minimal caregiver training.

Conical nasal adapter made of soft material that adapts to the patient’s nostril.

Graduated syringe with marks every 0.1 ml, allows to quantify the drugs to be delivered.

When applying high pressure to the syringe piston, ATOREX devices atomise medications into a fine mist of particles 30-100 microns in size.

Standard Female Luer Lock connector.

ATOREX LT – Laryngo-tracheal mucosal atomization device

ATOREX provides safe delivery of topical anesthesia directly to the airway mucosa. A fine mist of atomized particles is rapidly absorbed across mucosal membranes into the bloodstream.

It reduces the need for intravenous access that can often be painful and upsetting for the patient.

Delivery of atomised medication is also relatively painless and requires minimal caregiver training.

ATOREX allows for increased patient compliance during difficult and awake intubations.

ATOREX reduces airway and cardiovascular responses to mechanical stimulation permitting less stressful intubation and extubation.

Pliable extension that allows it to adapt to the anatomy of both adult and pediatric patients and easily reach various parts of the airways, up to the trachea.

Graduated syringe with marks every 0.1 ml, allows to quantify the drugs to be delivered.

Standard Female Luer Lock connector.

_References

_{Thomas Fuehner, Jan Fuge, Meike Jungen, Anna Buck, Hendrik Suhling, Tobias Welte, Jens Gottlieb, Mark Greer. Topical Nasal Anesthesia in Flexible Bronchoscopy–A Cross-Over Comparison between Two Devices.

PLoS One 2016 Mar 15; 11(3):e0150905}.

_{C Fantacci, G C Fabrizio, P Ferrara, F Franceschi, A Chiaretti. Intranasal drug administration for procedural sedation in children admitted to pediatric Emergency Room.

Eur Rev Med Pharmacol Sci 2018 Jan; 22(1):217-222.}

_{Zhubin Xie, Weihua Shen, Jingyi Lin, Liwen Xiao, Minyan Liao, Xiaoliang Gan. Sedation eﬀects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation.

Am J Emerg Med 2017 Aug;35(8):1126-1130.}

_{Maija Holsti, Benjamin L Sill, Sean D Firth, Francis M Filloux, Steven M Joyce, Ronald A Furnival. Prehospital intranasal midazolam for the treatment of pediatric seizures.

Pediatr Emerg Care 2007 Mar;23(3):148-53.}

_{Yiuka Leung, Francis X Vacanti. Awake without complaints: maximizing comfort during awake ﬁberoptic intubation.

J Clin Anesth 2015 Sep;27(6):517-9.}

_{Koichi Maruyama, Hironori Sakai, Hideki Miyazawa, Kyou Iijima, Naoyuki Toda, Shuji Kawahara,Katsumi Hara. Laryngotracheal application of lidocaine spray increases the incidence ofpostoperative sore throat after total intravenous anesthesia.

J Anesth 2004;18(4):237-40.}

_{T Mihara, K Uchimoto, S Morita, T Goto. The eﬃcacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis.

Anaesthesia 2014 Dec;69(12):1388-96.}